The downregulation of fructose-1,6-biphosphatase (FBP1) by epigenetic mechanisms increased the rate of glycolysis but decreased the ROS level in basal-like breast cancer, resulting in the activation of β-catenin signaling to maintain CSCs [36]. The gene discussed is FBP1; the disease is breast cancer.